Startups channel feed

An im­munother­a­py pill for pso­ri­a­sis? Es­calier gets $19M Se­ries B to tack­le R&D

8 years ago

Pre­vail grabs $75M A round in the hunt for new gene ther­a­pies to stop the de­struc­tion caused by Parkin­son's

8 years ago
Financing

SF tech start­up Atom­wise gets $45M for AI-pow­ered drug de­sign soft­ware

8 years ago
Financing
AI

Is tech mon­ey bad for busi­ness? Sil­i­con Val­ley cash makes some bio­phar­ma VCs bris­tle, oth­ers cheer

8 years ago
Financing
Bioregnum

Unum plays its first glimpse of hu­man da­ta in an $86M IPO, re­veal­ing two deaths and an FDA hold

8 years ago
Financing
Pharma

Asian in­vestor com­mits $15M to launch new pro­tein degra­da­tion biotech start­up Cull­gen out of UNC

8 years ago

Dana-Far­ber’s Lau­rie Glim­ch­er helps launch a NYC biotech up­start with some key in­sights on im­muno-on­col­o­gy tech

8 years ago
Financing

Haul­ing in a $100M mega-round, gene ther­a­py start­up Gen­er­a­tion Bio builds al­ter­na­tive to po­ten­tial­ly risky vi­ral vec­tors

8 years ago
Financing
Cell/Gene Tx

Com­put­er sci­ence and en­gi­neer­ing, meet drug R&D. MIT star Tim­o­thy Lu in­ter­twines tech­nolo­gies for an off­beat biotech launch

8 years ago
Financing

Up­start GeneTx launch­es, go­ing head to head with Ovid on rare An­gel­man syn­drome

8 years ago

Is NYC a biotech hub? Gut-brain start­up Kally­ope, equipped with $66M in new mon­ey, says yes

8 years ago
Financing

Se­nior R&D ex­ec Sue Dil­lon jumps ship at J&J, launch­es mys­tery biotech start­up Aro with Cen­tyrins tech

8 years ago

Roche pays $1.9B for Ex-Googlers’ tech start­up Flat­iron Health

8 years ago
Deals

Sil­i­con Val­ley celebs chip in­to $250M round for age-fight­ing start­up Celu­lar­i­ty. Pla­cen­ta-based CAR-Ts on the hori­zon?

8 years ago

Ge­nomics meets blockchain: Har­vard team fea­tur­ing George Church launch­es peer-to-peer genome se­quenc­ing start­up

8 years ago

Tak­ing on lousy side ef­fects of ex­ist­ing meds, NEA-backed Xoc tack­les Parkin­son’s/mi­graines with $30M Se­ries A

8 years ago
Financing

With a po­ten­tial cure for lyso­so­mal stor­age dis­or­ders in hand, Avro­bio rais­es $60M to back gene ther­a­py pipeline

8 years ago
Financing
Cell/Gene Tx

Start­up with Johns Hop­kins roots rais­ing $40.5 mil­lion to de­vel­op can­cer me­tab­o­lism drugs

8 years ago
Financing

A transpa­cif­ic biotech start­up com­bines Asian in­vestors and some se­ri­ous­ly trendy sci­ence out of MIT

8 years ago
AI

Can­cer drug to treat dwarfism? Aban­doned No­var­tis as­set snagged by Bridge­Bio’s QED Ther­a­peu­tics

8 years ago

Mer­ck spin­out grabs some as­sets and launch­es a quest for the Holy Grail in an­tibi­otics R&D

8 years ago

Ex-Mer­ri­mack CEO Mul­roy launch­es on­col­o­gy start­up Part­ner Ther­a­peu­tics

8 years ago
Outsourcing

The new se­r­i­al en­tre­pre­neur in the biotech are­na launch­es an­oth­er up­start look­ing to drug RNA

8 years ago

When VCs hand out mega-rounds to Vir and Gos­samer, are they bet­ting on the jock­ey or the horse?

8 years ago
Financing
First page Previous page 64656667686970 Next page Last page
A service from the Financial Times